Serologic Phenotypes Distinguish SLE Patients with Myositis And/or Interstitial Lung Disease (ILD)

被引：0
|
作者：
Cotton, Thaisa [1 ]
Fritzler, Marvin [2 ]
Choi, May [3 ]
Zheng, Boyang [4 ]
Niaki, Omid Zahedi [5 ]
Grenier, Louis-Pierre [5 ]
Vinet, Evelyne [6 ]
Pineau, Christian [1 ]
Lukusa, Luck [7 ]
Kalache, Fares [5 ]
Bernatsky, Sasha [1 ]
机构：
[1] McGill Univ, Montreal, PQ, Canada
[2] Univ Calgary, Calgary, AB, Canada
[3] Univ Calgary, Brigham & Womens Hosp, Calgary, AB, Canada
[4] Univ British Columbia, Vancouver, BC, Canada
[5] McGill Univ, Hlth Ctr, Montreal, PQ, Canada
[6] McGill Univ, Hlth Ctr, Mont Royal, PQ, Canada
[7] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0330
引用
收藏
页码：670 / 673
页数：4
相关论文
共 50 条
  • [31] Management of Interstitial Lung Disease in Patients With Myositis Specific Autoantibodies
    Mecoli, Christopher A.
    Christopher-Stine, Lisa
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (05)
  • [32] Myositis interstitial lung disease and autoantibodies
    Chaudhry, Shire
    Christopher-Stine, Lisa
    FRONTIERS IN MEDICINE, 2023, 10
  • [33] Myositis Antibodies and Interstitial Lung Disease
    Basuita, Manpreet
    Fidler, Lee M.
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2022, 7 (01): : 240 - 258
  • [34] Management of Interstitial Lung Disease in Patients With Myositis Specific Autoantibodies
    Christopher A. Mecoli
    Lisa Christopher-Stine
    Current Rheumatology Reports, 2018, 20
  • [35] IMPACT OF PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE (ILD) IN ILD PATIENTS COMPLICATED WITH SECONDARY SPONTANEOUS PNEUMOTHORAX
    Yamakawa, Hideaki
    Tsukahara, Yuta
    Sato, Shintaro
    Ohta, Hiroki
    Kida, Gen
    Nakamura, Tomohiko
    Nishizawa, Tomotaka
    Kawabe, Rie
    Oba, Tomohiro
    Akasaka, Keiichi
    Amano, Masako
    Kuwano, Kazuyoshi
    Sasaki, Hiroki
    Takemura, Tamiko
    Matsushima, Hidekazu
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2021, 38 (04)
  • [36] SFTPA mutations in interstitial lung disease (ILD) and lung cancer
    Nathan, Nadia
    Legendre, Marie
    Kannengiesser, Caroline
    Albuisson, Juliette
    Borie, Raphael
    Bouvry, Diane
    Copin, Bruno
    Crestani, Bruno
    Dalphin, Jean-Charles
    Le Moal, Florence Dastot
    De Vuyst, Paul
    Duquesnoy, Philippe
    Filhol-Blin, Emilie
    Giraud, Violaine
    Gomez, Carine
    Gouya, Laurent
    Jeunemaitre, Xavier
    Nau, Valerie
    Nunes, Hilario
    Picard, Clement
    Prevost, Gregoire
    Reynaud-Gaubert, Martine
    Amselem, Serge
    Clement, Annick
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [37] The ILD-GAP risk prediction model performs poorly in myositis-associated interstitial lung disease
    Brusca, Rebeccah M.
    Pinal-Fernandez, Iago
    Psoter, Kevin
    Paik, Julie J.
    Albayda, Jemima
    Mecoli, Christopher
    Tiniakou, Eleni
    Mammen, Andrew L.
    Christopher-Stine, Lisa
    Danoff, Sonye
    Johnson, Cheilonda
    RESPIRATORY MEDICINE, 2019, 150 : 63 - 65
  • [38] Functional Follow-Up Of Diffuse Interstitial Lung Disease (ild) In Phenotypes Of Systemic Sclerosis (ssc)
    Mateos-Toledo, H.
    Sarmiento-Padilla, G.
    Mejia, M.
    Castillo-Pedroza, J.
    Buendia-Roldan, I.
    Estrada, A.
    Vargas-Dominguez, C.
    Rojas-Serrano, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [39] SURFACTANT PHOSPHOLIPIDS IN BRONCHOALVEOLAR LAVAGE OF PATIENTS WITH INTERSTITIAL LUNG-DISEASE (ILD)
    ROBINSON, PC
    KING, TE
    WATTERS, LC
    HALE, SG
    SCHWARZ, MI
    MASON, RJ
    CHEST, 1984, 86 (02) : 300 - 300
  • [40] Facilitating Factors for Home and Hospice Deaths in Interstitial Lung Disease (ILD) Patients
    Archibald, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345